Skip to NavigationSkip to content

News

Florida firm Catalyst Pharmaceuticals is suing the FDA after the agency approved a rival’s drug.
The FDA will offer priority review to Genentech’s supplemental biologics-license application (sBLA) application for Rituxan for children with two...
Swedish rare disease specialist Sobi has agreed to buy Swiss firm Novimmune ion a deal worth more than £400 million.
A California court has said Johnson & Johnson and Colgate-Palmolive must pay a total of nearly $10 million to a woman who developed cancer.
AstraZeneca’s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of £330 million that the firm budgeted...
Fewer opioids are prescribed in states with legal medical marijuana, according to research from University of Texas Medical Branch at Galveston.
The role Johnson & Johnson played in the opioid crisis was ‘in some ways worse’ than that of Purdue Pharma, an expert witness said in the...
Novo Nordisk’s oral diabetes drug semaglutide is safe for those at high risk of cardiovascular complications, according to the results of a Phase...
Ebola has spread to Uganda, according to the WHO.
MPs yesterday discussed circumventing Vertex’s patent on cystic fibrosis medicine Orkambi (Lumacaftor/ivacaftor) as a means of breaking the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches